Western Health Advantage
Yonsa (abiraterone, submicronized)
Drugs for Cancer : Drugs for Cancer
  • COPD (oral):
    Age Requirement: >= 18
    Duration: 12 Month(s)
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    COPD associated with chronic bronchitis: No
    History of COPD exacerbation: No
    Documented Diagnosis: Yes

  • Step Therapy: Ankylosing Spondylitis (AS):
    ST Multiple Generics

    Juvenile Idiopathic Arthritis, Psoriasis (PsO), Rheumatoid Arthritis (RA):
    ST Single Generic

  • Prior Authorization: Diabetic Medical Supplies:
    Documented Diagnosis: Yes
    Duration: 1 plan year
    Reauthorization Required: Yes

  • Prior Authorization: PA_APPLIES